SETTE, MARIA ROSARIA
 Distribuzione geografica
Continente #
NA - Nord America 86
EU - Europa 58
AS - Asia 46
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
Totale 206
Nazione #
US - Stati Uniti d'America 77
IT - Italia 38
CN - Cina 13
SG - Singapore 12
BD - Bangladesh 7
CA - Canada 5
RU - Federazione Russa 4
VN - Vietnam 4
DE - Germania 3
FI - Finlandia 3
FR - Francia 3
HK - Hong Kong 3
NL - Olanda 3
AR - Argentina 2
BR - Brasile 2
CO - Colombia 2
GB - Regno Unito 2
JM - Giamaica 2
BO - Bolivia 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
IN - India 1
IQ - Iraq 1
LC - Santa Lucia 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 200
Città #
Perugia 11
Council Bluffs 10
Singapore 8
Beijing 7
Milan 7
Santa Clara 7
Ashburn 5
Rome 5
San Jose 5
North Bergen 4
Amsterdam 3
Gualdo Cattaneo 3
Helsinki 3
Hong Kong 3
New York 3
Toronto 3
Castello di Cisterna 2
Ho Chi Minh City 2
Los Angeles 2
Miami 2
Moscow 2
Orem 2
Phoenix 2
Addis Ababa 1
Albuquerque 1
Ancona 1
Arouca 1
Atlanta 1
Barranquilla 1
Baños de Agua Santa 1
Berwyn 1
Boston 1
Calgary 1
Can Tho 1
Castries 1
Clifton Park 1
Corpus Christi 1
Dallas 1
Dayton 1
Derbent 1
Detroit 1
Dhaka 1
Driffield 1
Formosa 1
Fortaleza 1
Goodyear 1
Hamilton 1
Hanoi 1
Houston 1
Huntington 1
Ispra 1
Istanbul 1
Jeddah 1
Katy 1
Kingston 1
Lahore 1
Lancenigo-Villorba 1
Land O' Lakes 1
Lauterbourg 1
Lithonia 1
Mosul 1
Mumbai 1
Munich 1
Muscat 1
New Orleans 1
Nuremberg 1
Presidente Derqui 1
Princeton 1
Rio Branco 1
Saginaw 1
San Francisco 1
Santa Cruz de la Sierra 1
Savannah 1
Secaucus 1
Subang Jaya 1
Taylorsville 1
Toms River 1
West Palm Beach 1
Yumbo 1
Totale 157
Nome #
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 62
A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis 38
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma 37
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer 36
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer 20
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 13
Totale 206
Categoria #
all - tutte 1.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026120 0 0 7 7 6 2 5 10 30 31 8 14
2026/202786 13 9 23 41 0 0 0 0 0 0 0 0
Totale 206